Tag Archives: Mara Goldstein

Xencor (XNCR) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Xencor (XNCR – Research Report) yesterday and set a price target of $52.00. The company’s shares closed last Monday at $36.49. According to TipRanks.com, Goldstein is a 2-star analyst with

Mizuho Securities Maintains Their Hold Rating on Incyte (INCY)

Mizuho Securities analyst Mara Goldstein maintained a Hold rating on Incyte (INCY – Research Report) today and set a price target of $79.00. The company’s shares closed last Monday at $75.83, close to its 52-week low of $71.84. According to

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK) and Sol-Gel Technologies (NASDAQ: SLGL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK – Research Report) and Sol-Gel Technologies (SLGL – Research Report) with bullish sentiments. Merck & Company (MRK) Mizuho

Forty Seven (FTSV) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Forty Seven (FTSV – Research Report) today and set a price target of $37.00. The company’s shares closed last Monday at $39.03. According to TipRanks.com, Goldstein is a 1-star analyst

Forty Seven (FTSV) Gets a Buy Rating from Mizuho Securities

In a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Forty Seven (FTSV – Research Report), with a price target of $37.00. The company’s shares closed last Monday at $36.40. According to TipRanks.com, Goldstein is

Mizuho Securities Sticks to Its Hold Rating for Incyte (INCY)

In a report released today, Mara Goldstein from Mizuho Securities maintained a Hold rating on Incyte (INCY – Research Report), with a price target of $79.00. The company’s shares closed last Monday at $77.34. According to TipRanks.com, Goldstein is a